Skip to main content
OpenTrials
Completed

NCT Number: NCT04476810

Long Term Outcome of Combined Phacoemulsification and Excisional Goniotomy With the Kahook Dual Blade

Purpose: Characterize changes in intraocular pressure (IOP), IOP-lowering medications, and visual acuity (VA) through 3 years in patients undergoing combined phacoemulsification and excisional goniotomy with the Kahook Dual Blade (phaco-KDB), with simultaneous goniosynechialysis in cases of angle-closure glaucoma, by a single surgeon (A.H.) in King Fahd Hospital of the University, Dammam, Saudi Arabia.

Methods: Prospective, non-comparative, uncontrolled, non-randomized interventional case series. Consecutive patients with medically-treated glaucoma and visually-significant cataract underwent combined surgery. Subgroup analysis of glaucoma subtypes was performed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Angle Closure Glaucoma Cataract Eye Diseases Glaucoma, Angle-Closure Glaucoma, Open-Angle Lens Diseases Ocular Hypertension Surgery

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Imam Abdulrahman Bin Faisal University Hospital

Dammam, Saudi Arabia

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adults 18 years or older
  • medically-managed glaucoma
  • visually significant cataract

Exclusion criteria

  • Patients undergoing any other combined procedures
  • active uveitis
  • coexisting retinopathy that limits visual acuity potential
  • active neovascularization
  • angle dysgenesis
  • those with less than 6 months of follow-up, were excluded.

Treatment and study plan

kahook dual blade

Device

Combined Phacoemulsification and Excisional Goniotomy with the Kahook Dual Blade

Other names: phacoemulsification

Primary outcomes

  1. Intraocular pressure

    Time frame: 36 months

    Characterize changes in intraocular pressure (IOP) in mmHg goldmann applanation tonometry each visit in the clinic after the combined phacoemulsification and excisional goniotomy with the kahook dual blade.

  2. Intraocular pressure lowering medications

    Time frame: 36 months

    count the change in number of Intraocular pressure lowering medications each visit in the clinic after the combined phacoemulsification and excisional goniotomy with the kahook dual blade

Secondary outcomes

  1. Visual acuity

    Time frame: 36 months

    Characterize visual acuity (VA) using logMAR chart, each visit in clinic post undergoing combined phacoemulsification and excisional goniotomy with the kahook dual blade.

Sponsors and collaborators

Lead sponsor

Ahmed Al Habash

Other

Registry information

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Jul 20, 2020
Registry last updated
Jul 29, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.